Abstract
Twenty-five years after the emergence of powerful molecular recognition elements known as aptamers, these synthetic receptors are finding applications in therapeutics, imaging, diagnostics and biosensors. Comparisons have been drawn between aptamers and antibodies since their earliest days. This review will highlight how some of the most promising and successful aptamer-based applications have exploited the advantages aptamers have over their antibody counterparts and will point to future applications of this enabling technology.
Keywords: Antibodies, Aptamers, Biosensors, Imaging, SELEX, Therapeutics.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Outlook for Aptamers After Twenty Five Years
Volume: 15 Issue: 12
Author(s): Phepafatso K. Tsae and Maria C. DeRosa
Affiliation:
Keywords: Antibodies, Aptamers, Biosensors, Imaging, SELEX, Therapeutics.
Abstract: Twenty-five years after the emergence of powerful molecular recognition elements known as aptamers, these synthetic receptors are finding applications in therapeutics, imaging, diagnostics and biosensors. Comparisons have been drawn between aptamers and antibodies since their earliest days. This review will highlight how some of the most promising and successful aptamer-based applications have exploited the advantages aptamers have over their antibody counterparts and will point to future applications of this enabling technology.
Export Options
About this article
Cite this article as:
Tsae K. Phepafatso and DeRosa C. Maria, Outlook for Aptamers After Twenty Five Years, Current Topics in Medicinal Chemistry 2015; 15 (12) . https://dx.doi.org/10.2174/1568026615666150413154038
DOI https://dx.doi.org/10.2174/1568026615666150413154038 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Interrupting the Natural History of Diabetes Mellitus: Lifestyle, Pharmacological and Surgical Strategies Targeting Disease Progression
Current Vascular Pharmacology Anti-Inflammatory Treatments for Chronic Diseases: A Review
Inflammation & Allergy - Drug Targets (Discontinued) Rationale and Design of an Observational Study to Determine the Effects of Cholecalciferol on Hypertension, Proteinuria and Urinary MCP-1 in ADPKD
Current Hypertension Reviews Hormones and the Autonomic Nervous System are Involved in Suprachiasmatic Nucleus Modulation of Glucose Homeostasis
Current Diabetes Reviews Adipokines and Myokines: A Pivotal Role in Metabolic and Cardiovascular Disorders
Current Medicinal Chemistry The Metabolic Syndrome and the Relevance of Nutrients for its Onset
Recent Patents on Biotechnology The Effects of Antihypertensive Therapy on Haemostatic Parameters
Current Pharmaceutical Design Novel Patents and Cancer Therapies for Transforming Growth Factor- Beta and Urokinase Type Plasminogen Activator: Potential Use of Their Interplay in Tumorigenesis
Recent Patents on Anti-Cancer Drug Discovery Role of Sulfur Containing Amino Acids as an Adjuvant Therapy in the Prevention of Diabetes and its Associated Complications
Current Diabetes Reviews Evaluation of B Lymphocyte Deficiencies
Cardiovascular & Hematological Disorders-Drug Targets Regulation of Catechins in Uric Acid Metabolism Disorder Related Human Diseases
Mini-Reviews in Medicinal Chemistry Acute Kidney Injury in Pediatric Heart Failure
Current Cardiology Reviews The Impact of Hypertension in Hemodialysis Patients
Current Hypertension Reviews Anti-Vasopermeability Effects of PEDF in Retinal-Renal Disorders
Current Molecular Medicine Flavonoids and Linderone from Lindera oxyphylla and their Bioactivities
Combinatorial Chemistry & High Throughput Screening Combination of Daidzein, Hemin and Bms182874 Halts the Progression of Diabetes-Induced Experimental Nephropathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting the Tumor Proteasome as a Mechanism to Control the Synthesis and Bioactivity of Matrix Macromolecules
Current Molecular Medicine Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology
Current Drug Targets Advanced Glycation End Products and Insulin Resistance
Current Pharmaceutical Design Evaluation of Response Surface Methodology to Predict Optimum Growth Conditions for Lactobacillus plantarum A7 (KC 355240) in Probiotic Soy Milk Containing Essential Oil of Cuminum cyminum
Recent Patents on Food, Nutrition & Agriculture